title: Gabapentin for treatment of behavioral and psychological symptoms of dementia.
abstract: OBJECTIVE
  To report the use of gabapentin in the treatment of behavioral and psychological symptoms of dementia (BPSD) and to review the available literature relating to the use of gabapentin in this population.
  
  
  METHODS
  A 62-year-old white man was admitted to the hospital due to a worsening state of confusion, anxiety, depressed mood, insomnia, and verbal and physical aggressiveness toward his wife. He had a past medical history significant for vascular dementia. He had been intolerant of or had failed to respond to numerous antidepressants, benzodiazepines, and neuroleptics. The addition of gabapentin to the patient's medication regimen resulted in reduced agitation, sexual inappropriateness, and lability. He was discharged to his home on a dose of gabapentin 300 mg three times daily.
  
  
  METHODS
  A MEDLINE search (1966-August 2000) was performed to identify case reports and clinical trials discussing the efficacy of gabapentin in the treatment of BPSD.
  
  
  CONCLUSIONS
  Gabapentin, like other anticonvulsants, has been used with success in several psychiatric illnesses. Available literature indicates that the drug may have some efficacy in the treatment of BPSD. It has a favorable adverse effect profile in the elderly, which makes it an attractive altemative to standard therapies, including benzodiazepines and neuroleptics. Optimal dosing remains unclear.
  
  
  CONCLUSIONS
  This case suggests that gabapentin is a reasonable alternative therapy for patients whose behavioral symptoms do not respond to conventional agents.
authors: Memorial Hermann Southwest Hospital, Houston, TX 77074-1802, USA. lisa_miller@MHHS.org
authors: L J
authors: LJ
authors: Miller
mesh_terms: D000085:Acetates / Q000627:therapeutic use*; D000374:Aggression; D000588:Amines; D001519:Behavior / Q000187:drug effects; D003509:Cyclohexanecarboxylic Acids; D015140:Dementia, Vascular / Q000188:drug therapy* / Q000523:psychology*; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use*; D000077206:Gabapentin; D006801:Humans; D008297:Male; D008875:Middle Aged; D005680:gamma-Aminobutyric Acid
chemical_list: D000085:Acetates; D000588:Amines; D003509:Cyclohexanecarboxylic Acids; D018691:Excitatory Amino Acid Antagonists; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin